Your browser doesn't support javascript.
loading
COVID-19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients.
Del Poeta, Giovanni; Laureana, Roberta; Bomben, Riccardo; Rossi, Francesca Maria; Pozzo, Federico; Zaina, Eva; Cattarossi, Ilaria; Varaschin, Paola; Nanni, Paola; Boschian Boschin, Romina; Nunzi, Andrea; Postorino, Massimiliano; Pasqualone, Gianmario; Brisotto, Giulia; Steffan, Agostino; Muraro, Elena; Zucchetto, Antonella; Del Principe, Maria Ilaria; Gattei, Valter.
Afiliación
  • Del Poeta G; Hematology, Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
  • Laureana R; Hematology, Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
  • Bomben R; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
  • Rossi FM; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
  • Pozzo F; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
  • Zaina E; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
  • Cattarossi I; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
  • Varaschin P; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
  • Nanni P; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
  • Boschian Boschin R; Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
  • Nunzi A; Hematology, Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
  • Postorino M; Hematology, Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
  • Pasqualone G; Hematology, Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
  • Brisotto G; Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
  • Steffan A; Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
  • Muraro E; Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
  • Zucchetto A; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
  • Del Principe MI; Hematology, Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy.
  • Gattei V; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Pordenone, Italy.
Hematol Oncol ; 41(3): 559-562, 2023 08.
Article en En | MEDLINE | ID: mdl-36585917
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / COVID-19 Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / COVID-19 Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia